Comparison

Dalbavancin HCl European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 50mg
Item no. TMO-T21358-50mg
CASRN 171500-79-1
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Dalbavancin, a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE), Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively
Shipping
cool pack
Storage
-20°
Target names or alias
VER 001 , BI-397 , A-A 1 , VER-001 , Dalbavancin HCl , BI397 , BI 397
Molecular Weight
1853, 17
Pathway
Microbiology/Virology
Target
Antibacterial|||Antibiotic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close